WallStreetZenWallStreetZen

NYSE: TAK
Takeda Pharmaceutical Co Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TAK past earnings growth

How has TAK's earnings growth performed historically?
Company
-55.91%
Industry
26.66%
Market
53.07%
TAK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
TAK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
TAK's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

TAK past revenue growth

How has TAK's revenue growth performed historically?
Company
-3.8%
Industry
37.31%
Market
16.68%
TAK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TAK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TAK's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TAK earnings and revenue history

Current Revenue
$28.0B
Current Earnings
$950.3M
Current Profit Margin
3.4%

TAK Return on Equity

Current Company
2.1%
Current Industry
11.7%
Current Market
34.1%
TAK's Return on Equity (2.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TAK announces earnings.

TAK Return on Assets

Current Company
1%
Current Industry
4.2%
TAK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TAK Return on Capital Employed

Current Company
2.08%
Current Industry
11.6%
TAK's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TAK vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TAK$28.92B$6.78B$982.70M+3.96%+7.74%
HLN$15.14B$3.08B$1.61B-1.77%+0.87%
TEVA$16.29B$2.23B-$476.00M-0.65%N/A
VTRS$15.24B$2.73B-$646.50M+6.19%N/A
RDY$3.35B$1.06B$668.31M+8.54%+19.65%
View Top Pharmaceutical Stocks

TAK earnings dates

Next earnings date
Oct 31, 2024

Takeda Pharmaceutical Co Earnings & Revenue FAQ

What were TAK's earnings last quarter?

On Invalid Date, Takeda Pharmaceutical Co (NYSE: TAK) reported Q2 2024 earnings per share (EPS) of $0.19, up 5.42% year over year. Total Takeda Pharmaceutical Co earnings for the quarter were $603.92 million. In the same quarter last year, Takeda Pharmaceutical Co's earnings per share (EPS) was $0.20.

If you're new to stock investing, here's how to buy Takeda Pharmaceutical Co stock.

What was TAK's earnings growth in the past year?

As of Q3 2024, Takeda Pharmaceutical Co's earnings has grown -55.91% year over year. This is 82.57 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 26.66%. Takeda Pharmaceutical Co's earnings in the past year totalled $982.70 million.

What is TAK's earnings date?

Takeda Pharmaceutical Co's earnings date is Invalid Date. Add TAK to your watchlist to be reminded of TAK's next earnings announcement.

What was TAK's revenue last quarter?

On Invalid Date, Takeda Pharmaceutical Co (NYSE: TAK) reported Q2 2024 revenue of $7.66 billion up 2.32% year over year. In the same quarter last year, Takeda Pharmaceutical Co's revenue was $7.48 billion.

What was TAK's revenue growth in the past year?

As of Q3 2024, Takeda Pharmaceutical Co's revenue has grown -3.8% year over year. This is 41.11 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 37.31%. Takeda Pharmaceutical Co's revenue in the past year totalled $28.92 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.